BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim ES, Song GA, Cho KB, Park KS, Kim KO, Jang BI, Kim EY, Jeon SW, Lee HS, Yang CH, Lee YK, Lee DW, Kim SK, Kim TO, Lee J, Kim HW, Jee SR, Park SJ, Kim HJ. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents. World J Gastroenterol 2015; 21(11): 3308-3316 [PMID: 25805938 DOI: 10.3748/wjg.v21.i11.3308]
URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3308.htm
Number Citing Articles
1
Helena Shifrin, Odelia Mouhadeb, Nathan Gluck, Chen Varol, Marta Weinstock. Cholinergic Anti-Inflammatory Pathway Does Not Contribute to Prevention of Ulcerative Colitis by Novel Indoline CarbamatesJournal of Neuroimmune Pharmacology 2017; 12(3): 484 doi: 10.1007/s11481-017-9735-8
2
Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasuo Suzuki, Kentaro Sugano, Mamoru Watanabe, Toshifumi Hibi, Amarender S. Puri, Suk-Kyun Yang. Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessmentIntestinal Research 2018; 16(1): 4 doi: 10.5217/ir.2018.16.1.4
3
Yu Zhou, Juan Du, Hong-Yan Hou, Yan-Fang Lu, Jing Yu, Li-Yan Mao, Feng Wang, Zi-Yong Sun. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis TherapyFrontiers in Cellular and Infection Microbiology 2017; 7 doi: 10.3389/fcimb.2017.00457
4
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract2020; : 388 doi: 10.1017/9781316823026.024
5
Nina Jahnich, Peter D. Arkwright. Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic reviewFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1046306
6
Hanif Esmail, Robert J. Wilkinson. Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF TherapyAnnals of the American Thoracic Society 2017; 14(5): 621 doi: 10.1513/AnnalsATS.201701-055ED
7
Ibrahim Abubakar, Ajit Lalvani, Jo Southern, Alice Sitch, Charlotte Jackson, Oluchukwu Onyimadu, Marc Lipman, Jonathan J Deeks, Chris Griffiths, Graham Bothamley, Onn Min Kon, Andrew Hayward, Joanne Lord, Francis Drobniewski. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test studyHealth Technology Assessment 2018; 22(56): 1 doi: 10.3310/hta22560
8
Jae Hee Cheon. Understanding the complications of anti‐tumor necrosis factor therapy in East Asian patients with inflammatory bowel diseaseJournal of Gastroenterology and Hepatology 2017; 32(4): 769 doi: 10.1111/jgh.13612
9
V.B. Pereira, V.P. da Cunha, T.M. Preisser, B.M. Souza, M.Z. Turk, C.P. De Castro, M.S.P. Azevedo, A. Miyoshi. Lactococcus lactiscarrying a DNA vaccine coding for theESAT-6antigen increases IL-17 cytokine secretion and boosts the BCG vaccine immune responseJournal of Applied Microbiology 2017; 122(6): 1657 doi: 10.1111/jam.13449
10
Saurabh Kedia, Venigalla Pratap Mouli, Nagesh Kamat, Jeeva Sankar, Ashwin Ananthakrishnan, Govind Makharia, Vineet Ahuja. Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-AnalysisAmerican Journal of Gastroenterology 2020; 115(3): 340 doi: 10.14309/ajg.0000000000000527
11
Dong II Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin‐Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasuo Suzuki, Kentaro Sugano, Mamoru Watanabe, Toshifumi Hibi, Amarender S Puri, Suk‐Kyun Yang. Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 1: Risk assessmentJournal of Gastroenterology and Hepatology 2018; 33(1): 20 doi: 10.1111/jgh.14019
12
Maede Ghanaeipour, Nima Behnaminia, Erfan Khadem, Amirhossein Nafari. The Risk of Opportunistic Infections in Patients with Inflammatory Bowel DiseaseThe International Journal of Gastroenterology and Hepatology Diseases 2022; 1(1) doi: 10.2174/2666290601666220124111511
13
Arisa Iba, Jun Tomio, Hayato Yamana, Takehiro Sugiyama, Takashi Yoshiyama, Yasuki Kobayashi. Tuberculosis screening and management of latent tuberculosis infection prior to biologic treatment in patients with immune‐mediated inflammatory diseases: A longitudinal population‐based analysis using claims dataHealth Science Reports 2020; 3(4) doi: 10.1002/hsr2.216
14
Hsiang-Chun Lai, Chia-Hsi Chang, Ken-Sheng Cheng, Tsung-Wei Chen, Yuan-Yao Tsai, Jen-Wei Chou. QuantiFERON-TB Gold Test Conversion Is Associated with Active Tuberculosis Development in Inflammatory Bowel Disease Patients Treated with Biological Agents: An Experience of a Medical Center in TaiwanGastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/7132875
15
Jungsil Lee, Eunyoung Kim, Eun Jin Jang, Chang-Hoon Lee, Eun Young Lee, Jong Pil Im, Sung Koo Han, Jae-Joon Yim. Efficacy of Treatment for Latent Tuberculosis in Patients Undergoing Treatment with a Tumor Necrosis Factor AntagonistAnnals of the American Thoracic Society 2017; 14(5): 690 doi: 10.1513/AnnalsATS.201608-647OC
16
S. N. Hong, H. J. Kim, K. H. Kim, S.‐J. Han, I. M. Ahn, H. S. Ahn. Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population‐based study in South KoreaAlimentary Pharmacology & Therapeutics 2017; 45(2): 253 doi: 10.1111/apt.13851
17
Diana Castillo-Martínez, Luis M. Amezcua-Castillo, Julio Granados, Carlos Pineda, Luis M. Amezcua-Guerra. Is Takayasu arteritis the result of a Mycobacterium tuberculosis infection? The use of TNF inhibitors may be the proof-of-concept to demonstrate that this association is epiphenomenalClinical Rheumatology 2020; 39(6): 2003 doi: 10.1007/s10067-020-05045-z
18
Anna Shin, Yun Jong Lee, Eun Bong Lee, Yeong Wook Song, Seoyoung C Kim, Eun Ha Kang. Tuberculosis risk with biologics by screening-guided preventive strategy in rheumatoid arthritis under intermediate tuberculosis burdenRheumatology 2021; 60(6): 2755 doi: 10.1093/rheumatology/keaa702
19
Ying Zhou, Chun-yan Tan, Zhi-jiang Mo, Qi-le Gao, Dan He, Jiong Li, Rong-fu Huang, Yan-bing Li, Chao-feng Guo, Qiang Guo, Long-jie Wang, Guan-teng Yang, Hong-qi Zhang. Polymorphisms in theSP110andTNF-αGene and Susceptibility to Pulmonary and Spinal Tuberculosis among Southern Chinese PopulationDisease Markers 2017; 2017: 1 doi: 10.1155/2017/4590235
20
Peeyush Kumar, Sudheer K. Vuyyuru, Bhaskar Kante, Pabitra Sahu, Sandeep Goyal, Deepak Madhu, Saransh Jain, Mukesh Kumar Ranjan, Sandeep Mundhra, Rithvik Golla, Mukesh Singh, Shubi Virmani, Anvita Gupta, Nidhi Yadav, Mani Kalaivani, Raju Sharma, Prasenjit Das, Govind Makharia, Saurabh Kedia, Vineet Ahuja. Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti‐TNF therapy in tuberculosis endemic regionAlimentary Pharmacology & Therapeutics 2022; 55(11): 1431 doi: 10.1111/apt.16839
21
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract2020;  doi: 10.1017/9781316823026
22
Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja. High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in IndiaIntestinal Research 2018; 16(4): 588 doi: 10.5217/ir.2018.00023
23
Yue Yu, Qiao Yu, Ke Ren Shen, Ding Ting Xu, Wen Hu, Shu Yan Li, Qing Shan Cai, Yan Chen. New‐onset extrapulmonary tuberculosis in negative latent tuberculosis infection screening patients with Crohn's disease under anti‐TNF therapy in a tuberculosis‐endemic region: A case seriesJournal of Digestive Diseases 2023; 24(5): 369 doi: 10.1111/1751-2980.13206
24
Jason K. Hou, Jennifer R. Kramer, Peter Richardson, Shubhada Sansgiry, Hashem B. El-Serag. Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha AntagonistsInflammatory Bowel Diseases 2017; 23(2): 254 doi: 10.1097/MIB.0000000000001003
25
Jae Yong Lee, Kyunghwan Oh, Hee Seung Hong, Kyuwon Kim, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Ho-Su Lee, Kyung-Wook Jo, Sang Hyoung Park. Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from KoreaBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01973-5
26
Jun Tomio, Hayato Yamana, Hiroki Matsui, Hiroyuki Yamashita, Takashi Yoshiyama, Hideo Yasunaga. Tuberculosis screening prior to anti‐tumor necrosis factor therapy among patients with immune‐mediated inflammatory diseases in Japan: a longitudinal study using a large‐scale health insurance claims databaseInternational Journal of Rheumatic Diseases 2017; 20(11): 1674 doi: 10.1111/1756-185X.13190
27
Aye Aye Thi, Aula Abbara, Sonia Bouri, Simon M Collin, Paul Wolfson, Leah Owen, Kevin G Buell, Laurence John, Ailsa L Hart. Challenges in screening for latent tuberculosis in inflammatory bowel disease prior to biologic treatment: a UK cohort studyFrontline Gastroenterology 2018; 9(3): 234 doi: 10.1136/flgastro-2017-100951
28
Michael Kwan‐Lung Ko, Siew C Ng, Lung‐Yi Mak, Michael K Li, Fu Hang Lo, Carmen Ka Man Ng, Wai Cheung Lao, Steve Tsang, Kam Hon Chan, Yee Tak Hui, Edwin Hok Shing Shan, Ching Kong Loo, Aric J Hui, Wai Pan To, Ivan F Hung, Wai K Leung. Infection‐related hospitalizations in the first year after inflammatory bowel disease diagnosisJournal of Digestive Diseases 2016; 17(9): 610 doi: 10.1111/1751-2980.12397
29
Jang Wook Lee, Chang Hwan Choi, Ji Hoon Park, Jeong Wook Kim, Sang Bum Kang, Ja Seol Koo, Young-Ho Kim, You Sun Kim, Young Eun Joo, Sae Kyung Chang. Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel diseaseIntestinal Research 2016; 14(2): 146 doi: 10.5217/ir.2016.14.2.146
30
Hyeonseok Noh, Jeongju Jang, Seungwon Kwon, Seung-Yeon Cho, Woo-Sang Jung, Sang-Kwan Moon, Jung-Mi Park, Chang-Nam Ko, Ho Kim, Seong-Uk Park. The Impact of Korean Medicine Treatment on the Incidence of Parkinson’s Disease in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study in South KoreaJournal of Clinical Medicine 2020; 9(8): 2422 doi: 10.3390/jcm9082422
31
Guilherme P Ramos, Gregory Stroh, Badr Al-Bawardy, William A Faubion, Konstantinos A Papadakis, Patricio Escalante. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic TherapyInflammatory Bowel Diseases 2018; 24(10): 2272 doi: 10.1093/ibd/izy133
32
Flora Maria Lorenzo Fortes, Ney Boa Sorte, Victor D Mariano, Laíla D Andrade, Fernanda A Oliveira, Monique CA Santos, Cláudia Ivanilda N dos Santos, Catharina A Passos, Mila P Pacheco, Valdiana C Surlo, Neogélia P de Almeida, Jaciane AM Fontes, Andréa M Pimentel, Raquel Rocha, Genoile Oliveira Santana. Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin AmericaWorld Journal of Gastroenterology 2020; 26(44): 6993-7004 doi: 10.3748/wjg.v26.i44.6993
33
Suprabhat Giri, Sukanya Bhrugumalla, Akash Shukla, Sagar Gangadhar, Srujan Reddy, Sumaswi Angadi, Leela Shinde, Aditya Kale. Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screeningArab Journal of Gastroenterology 2024;  doi: 10.1016/j.ajg.2024.01.013